PMID- 31000202 OWN - NLM STAT- MEDLINE DCOM- 20200623 LR - 20200623 IS - 1090-2104 (Electronic) IS - 0006-291X (Linking) VI - 513 IP - 4 DP - 2019 Jun 11 TI - Dysregulation of humoral immunity in Foxp3 conditional-knockout mice. PG - 787-793 LID - S0006-291X(19)30732-6 [pii] LID - 10.1016/j.bbrc.2019.04.090 [doi] AB - Foxp3(+) regulatory T cells (Tregs) are crucial for maintaining tolerance to self-antigens and preventing autoimmune diseases. Loss of Foxp3 expression leads to autoimmunity and disrupts humoral immune responses, including hyperproduction of immunoglobulin E (IgE). Elucidation of how Tregs control antibody production can lead to the development of new therapies for autoimmune and allergic diseases. However, premature death of Foxp3-deficient mice makes it difficult to analyze the roles of Tregs in humoral immunity of adult mice. In this study, we developed Foxp3 conditional-knockout mice (Foxp3(flox)R26(CreERT2)) in which the Foxp3 gene was inducibly deleted by tamoxifen administration. After oral administration of tamoxifen, titers of immunoglobulins, particularly IgG2c and IgE, were increased in Foxp3(flox)R26(CreERT2) mice compared with that in controls. Under these conditions, CD4(+) T cells from Foxp3(flox)R26(CreERT2) mice had increased expression of several activation markers, including inducible costimulator and CD40 ligand, as well as the cytokines interleukin 4 and interferon gamma. In addition, the proportions of T follicular helper (Tfh) cells and germinal center (GC) B cells were increased in Foxp3(flox)R26(CreERT2) mice compared with those in controls. These results indicated that Tregs controlled excessive or pathogenic antibody production by suppressing Tfh cell differentiation and GC formation. Furthermore, these data suggested that Foxp3(flox)R26(CreERT2) mice could be a useful tool for screening therapeutic agents. CI - Copyright (c) 2019 Elsevier Inc. All rights reserved. FAU - Tai, Yuki AU - Tai Y AD - Laboratory of Pharmaceutical Immunology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan. FAU - Sakamoto, Kazuki AU - Sakamoto K AD - Laboratory of Pharmaceutical Immunology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan. FAU - Takano, Azumi AU - Takano A AD - Laboratory of Pharmaceutical Immunology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan. FAU - Haga, Katsura AU - Haga K AD - Laboratory of Pharmaceutical Immunology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan. FAU - Harada, Yohsuke AU - Harada Y AD - Laboratory of Pharmaceutical Immunology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan. Electronic address: yohsuke@rs.noda.tus.ac.jp. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190415 PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (Forkhead Transcription Factors) RN - 0 (Foxp3 protein, mouse) SB - IM MH - Animals MH - Antibody Formation/immunology MH - B-Lymphocytes/immunology MH - Forkhead Transcription Factors/*deficiency/metabolism MH - Gene Deletion MH - Germinal Center/immunology MH - *Immunity, Humoral MH - Lymphocyte Activation/immunology MH - Mice, Knockout MH - T-Lymphocytes, Helper-Inducer/immunology OTO - NOTNLM OT - Cells OT - Germinal center OT - Humoral immunity OT - Regulatory T cells OT - T follicular helper EDAT- 2019/04/20 06:00 MHDA- 2020/06/24 06:00 CRDT- 2019/04/20 06:00 PHST- 2019/02/06 00:00 [received] PHST- 2019/04/05 00:00 [revised] PHST- 2019/04/12 00:00 [accepted] PHST- 2019/04/20 06:00 [pubmed] PHST- 2020/06/24 06:00 [medline] PHST- 2019/04/20 06:00 [entrez] AID - S0006-291X(19)30732-6 [pii] AID - 10.1016/j.bbrc.2019.04.090 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 2019 Jun 11;513(4):787-793. doi: 10.1016/j.bbrc.2019.04.090. Epub 2019 Apr 15.